Suppr超能文献

新生儿的止血障碍与呼吸窘迫

Haemostatic disorders and respiratory distress in the newborn.

作者信息

Boyer C, Ménaché D, Beaufils F, Mathieu H

出版信息

Intensive Care Med. 1977 Dec;3(4):273-8. doi: 10.1007/BF01641119.

Abstract

Coagulation and fibrinolysis studies were performed on 64 newborns; 16 premature infants with hyaline membrane disease (HMD), 17 newborns with other forms of respiratory distress syndrome (RDS) (8 of them were premature), 31 healthy newborns (11 of them were premature). All the babies were studied once in the first 48 hours of life. There was no significant difference between sick and healthy babies for 5 parameters; platelet count, factor VIII, fibrinogen, fibrin(ogen) degradation products, euglobulin lysis time. Factor II, VII and X were low in all infants, and premature infants had significantly lower levels compared to full term newborns. Factor V, plasminogen, alpha 2 macroglobulin (alpha 2M) and antithrombin III (AT III) levels were significantly lower in sick infants. Except for AT III, these deficiencies were not related to prematurity. No significant difference was found between HMD and other RDS. Of the 33 sick infants, 5 developed laboratory findings consistent with disseminated intravascular coagulation (DIC). The results indicate that the coagulation and fibrinolytic abnormalities reported are not specific to HMD.

摘要

对64名新生儿进行了凝血和纤溶研究;16名患有透明膜病(HMD)的早产儿,17名患有其他形式呼吸窘迫综合征(RDS)的新生儿(其中8名是早产儿),31名健康新生儿(其中11名是早产儿)。所有婴儿在出生后的头48小时内均接受了一次研究。在血小板计数、因子VIII、纤维蛋白原、纤维蛋白(原)降解产物、优球蛋白溶解时间这5项参数上,患病婴儿和健康婴儿之间没有显著差异。所有婴儿的因子II、VII和X均较低,与足月儿相比,早产儿的水平显著更低。患病婴儿的因子V、纤溶酶原、α2巨球蛋白(α2M)和抗凝血酶III(AT III)水平显著更低。除了AT III外,这些缺乏与早产无关。在HMD和其他RDS之间未发现显著差异。在33名患病婴儿中,5名出现了与弥散性血管内凝血(DIC)一致的实验室检查结果。结果表明,所报告的凝血和纤溶异常并非HMD所特有。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验